- 专利标题: ANTIBODY-DRUG CONJUGATE AND USE THEREOF
-
申请号: EP20765892.3申请日: 2020-03-06
-
公开(公告)号: EP3936151A1公开(公告)日: 2022-01-12
- 发明人: JUNG, Jinwon , KIM, Juhee , PAK, Youngdon , SONG, Daehae , YEOM, Donghoon , EOM, Jaehyun , HONG, Youngeun , LEE, Bora
- 申请人: ABL Bio, Inc.
- 申请人地址: KR Seongnam-si, Gyeonggi-do 13488 2F, 16, Daewangpangyo-ro 712 beon-gil Bundang-gu
- 代理机构: Mewburn Ellis LLP
- 优先权: US201962814982 P 20190307
- 国际公布: WO2020180158 20200910
- 主分类号: A61K47/68
- IPC分类号: A61K47/68 ; A61P35/00 ; C07H3/02 ; C07K16/28 ; A61K39/00
摘要:
The present invention relates to a novel compound comprising a galactose trigger moiety and cyclopropabenzindole (CBI), and an antibody-drug conjugate prepared by using same.
信息查询
IPC分类: